Powering pharma’s commercial teams with market access insights
Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans. Biopharma...
View ArticleHow to maximise the value of digital in medtech
With a wealth of market and regulatory changes impacting the medtech sector, it’s time for digital technology to steer the direction of your future business. This expert webinar will evaluate how to...
View ArticleUNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science
How can we create smarter, more effective communications for HCPs and patients? What can be done to challenge the status quo, apply a different mindset to communications, and deliver the best possible...
View ArticleThe evolution of pharma social media intelligence
Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights? As shown in the consumer world, social media can be a very rich source of insights into...
View ArticleImproving commercial decisions with customer relationship network insights
Networks of influence are shifting the decision-making process for life sciences companies. It is no longer enough to simply view the profile of a HCP or HCO to understand their value to your...
View ArticleDriving positive change for patients through collaboration and education
Change Together – www.changetogether.com – will be presenting a live webinar with leading figures from the patient advocacy community, who will debate how we can drive positive change for patients...
View ArticleUK pharma and integrated health
The concept of integrated healthcare is not new to the UK, where it has been discussed since the late 1960s. The difference is that now it could really happen. Technology, medicine, regulation and...
View ArticleDigital health: how can technology be used to engage hard-to-reach patients?
Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are asked to manage multiple physical and psychological symptoms while following complicated drug...
View ArticleUsing education and awareness to drive positive change for patients
Change Together will be presenting a live webinar with leading figures from the patient advocacy community, who will debate how we can drive positive change for patients through improved education and...
View ArticleHow to make digital work in medtech
The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech. It’s transforming how the sector...
View ArticleEngaging with HCPS: what do HCPs want from medical meetings?
There has been a myriad of reasons over the past few years to safely assume the popularity and perceived worth of face-to-face medical meetings was well and truly on the decline – from advances in...
View ArticleRealising the biotech promise: addressing the path to market
Now more than ever before, Biotech is the engine for innovation in medicine, finding, creating and delivering ground-breaking treatments to patients. The journey from molecule discovery and development...
View ArticleEngaging with patient communities – tailoring approaches
Change Together will be presenting a live webinar with leading figures from the patient advocacy community, who will discuss communication and engagement as well as the different approaches advocacy...
View ArticleDigital therapeutics and healthcare innovation
Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment...
View ArticleCan simulated datasets unlock the potential of patient data?
Patient level data offers the promise of insights which can craft new and better pathways, enable development of innovative therapies and treatments, and of course identify and prevent diseases much...
View ArticleThe devil’s in the e-detail: what HCPs really want from you
Overview: Communication; we all do it, it is a critical part of effective business practice and in this pharma is no exception. It is no secret that for pharma companies, face time with healthcare...
View ArticleMetrics to meaning: demonstrating the value of medical communications
Medical affairs and publications teams are under increasing pressure to demonstrate effectively the success of the medical communications activities they undertake. Naturally, there are a huge number...
View ArticleCancer, genomics and personalised medicine: Modelling the future of oncology
The prevalence of cancer is currently predicted to be higher than ever. Current statistics show 1 in 2 people in the UK and 1 in 2 men/1 in 3 women in the US will experience it at some stage in their...
View ArticleJust What the Dr Ordered for UK Life Sciences? The 2nd Life Sciences Sector Deal
Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the...
View ArticleNavigating new frontiers: Ways to find space in the future RA market
Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab). The...
View Article
